NUGX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (17 May 2023 @ 21:42):

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines...

Stats
今日成交量	1.00
平均成交量	122.00
市值	10 030.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00167
ATR14	$0.0360 (36 000.00%)

音量相关性

長: 0.00 (neutral)

短: 0.00 (neutral)

Signal:(47.227) Neutral

NuGenerex 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

NuGenerex 相关性 - 货币/商品

-0.06
( neutral )

0.12
( neutral )

0.00
( neutral )

0.13
( neutral )

0.00
( neutral )

0.02
( neutral )

NuGenerex 财务报表

Annual	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.0158

FY	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.0158

FY	2019
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.0110

Financial Reports:

No articles found.

NuGenerex

NuGenerex Immuno-Oncology, Inc., an oncology company, focuses on the modulation of the immune system to treat cancer. The company is developing immunotherapeutic products and vaccines. It is developing AE37, a peptide immunotherapeutic vaccine, which is in Phase II clinical trials for the treatment of metastatic triple negative breast cancer. The company was formerly known as Antigen Express, Inc. The company was founded in 1993 and is based in Miramar, Florida. NuGenerex Immuno-Oncology, Inc.is a subsidiary of Generex Biotechnology Corporation.